Breadcrumb

CORE News

Two awards for Dr. Robyn Tamblyn

Over the last several months Robyn Tamblyn, PhD, senior scientist at the Research Institute of the McGill University Health Centre...

Madhukar Pai invited to first-ever UN High Level Meeting on Tuberculosis

Dr. Madhukar Pai, Director of McGill's International Tuberculosis Centre, Director of McGill Global Health Programs and a scientist at the...

The Journey of a USBJI Young Investigator in Research

In the September edition of the United States Bone and Joint Initiative (USBJI) Newsletter, Sasha Bernatsky, MD, PhD, FRCPC...

Life-saving epinephrine underused during anaphylaxis outside of hospital, study finds

Fewer than half of adults and children experiencing food-induced anaphylaxis use their epinephrine autoinjector (EAI) before being...

Latent TB Treatment: Shorter is Better

Treatment of latent tuberculosis (TB) is set to transform after two studies from the Research Institute of the McGill University Health Centre...

Canadians are aging well, but ...

It's not every day that one receives a call from a researcher asking if they want to participate in a study on aging for the next 20 years of their...

Living with the stigma of diabetes

Michael Wright was your average high school student, juggling the responsibilities of school and friends while taking the first steps towards...

Arthritis Drugs Potentially Safe for Expectant Mothers

A new study led by a team at the Research Institute of the MUHC (RI-MUHC) in Montreal has revealed that pregnant women with...

Major funding awarded to RI-MUHC scientists for innovative genomics geared to Quebec patients

Pioneering work to advance genomics and precision health treatments at the Research Institute of the McGill University Health Centre...

Tackling adherence to treatment on several fronts

Learning to become self-sufficient and responsible is part of life’s journey through the teen and young adult years. Mistakes are often...

Explore news and events at the RI-MUHC